SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (121)11/14/1996 8:54:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Bennett, I had my abstract theory put to rest as Idec informed me that indeed their abstract is included in what the ASH sent to out but they don't have any detailed results in the abstract. I'm not sure what the abstracts would show if they didn't have any results but that is what I was told. Idec will be releasing the results of the phase III using C2B8 as a stand alone treatment as well as a full update on the status and duration of responses in the C2B8/chemo trial. If you remember the past 2 releases on this chemo study were extremely positive for the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext